$225 Million is the total value of KOPP INVESTMENT ADVISORS LLC's 81 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 47.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OMCL | Sell | Omnicell Inc. | $5,071,000 | -5.7% | 134,463 | -12.3% | 2.26% | -5.2% |
| STKL | Sell | SunOpta, Inc. | $4,561,000 | -28.9% | 425,056 | -29.7% | 2.03% | -28.5% |
| IDTI | Sell | Integrated Device Technology Inc. | $3,640,000 | -4.8% | 167,750 | -12.2% | 1.62% | -4.3% |
| SWKS | Sell | Skyworks Solutions | $3,392,000 | -25.9% | 32,584 | -30.0% | 1.51% | -25.4% |
| RKUS | Sell | Ruckus Wireless Inc. | $2,874,000 | -30.1% | 278,028 | -13.0% | 1.28% | -29.7% |
| PODD | Sell | Insulet Corp. | $2,623,000 | -13.9% | 84,640 | -7.4% | 1.17% | -13.4% |
| PTX | Sell | Pernix Therapeutics Holdings, | $2,297,000 | -70.2% | 388,000 | -46.2% | 1.02% | -70.0% |
| QRVO | Sell | Qorvo | $1,944,000 | +0.1% | 24,214 | -0.7% | 0.87% | +0.7% |
| MAR | Sell | Marriott Intl. Inc.cl a | $1,160,000 | -7.6% | 15,592 | -0.3% | 0.52% | -7.0% |
| EGRX | Sell | Eagle Pharmaceuticals, Inc. | $409,000 | -18.2% | 5,052 | -57.6% | 0.18% | -17.6% |
| SSH | Exit | Sunshine Heart, Inc | $0 | – | -14,950 | -100.0% | -0.03% | – |
| TECH | Exit | Bio-Techne Corp. | $0 | – | -2,000 | -100.0% | -0.09% | – |
| EVDY | Exit | Everyday Health, Inc. | $0 | – | -17,460 | -100.0% | -0.10% | – |
| DTLK | Exit | Datalink Corp. | $0 | – | -46,649 | -100.0% | -0.25% | – |
| STRM | Exit | Streamline Health Solutions Inc. | $0 | – | -288,117 | -100.0% | -0.45% | – |
| EXTR | Exit | Extreme Networks, Inc. | $0 | – | -582,027 | -100.0% | -0.81% | – |
| 4305PS | Exit | Alcatel Lucent Spons ADRsponsored adr | $0 | – | -817,154 | -100.0% | -1.35% | – |
| KFX | Exit | Kofax Ltd | $0 | – | -291,013 | -100.0% | -1.41% | – |
| VTSS | Exit | Vitesse Semiconductor Corporation | $0 | – | -5,770,732 | -100.0% | -13.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 26 | Q3 2019 | 8.2% |
| RTI Surgical Inc. | 26 | Q3 2019 | 6.0% |
| Omnicell Inc. | 26 | Q3 2019 | 4.7% |
| AtriCure Inc. | 26 | Q3 2019 | 4.6% |
| Ligand Pharmaceuticals Inc. | 26 | Q3 2019 | 4.5% |
| SPDR Trust Ser 1 | 26 | Q3 2019 | 2.3% |
| Marriott Intl. Inc. | 26 | Q3 2019 | 1.5% |
| Southwest Airls Co. | 26 | Q3 2019 | 1.3% |
| 3M Company | 26 | Q3 2019 | 1.2% |
| Aflac Incorporated | 26 | Q3 2019 | 1.1% |
View KOPP INVESTMENT ADVISORS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SUPERCONDUCTOR TECHNOLOGIES INC | August 19, 2016 | 528,963 | 16.6% |
| EMCORE CORP | April 01, 2016 | 1,248,970 | 4.8% |
| VITESSE SEMICONDUCTOR CORP | May 05, 2015 | ? | ? |
| TRANSGENOMIC INC | May 23, 2014 | 83,502 | 1.1% |
| RTI SURGICAL, INC. | January 03, 2014 | 1,984,618 | 3.5% |
| SYNERGETICS USA INC | January 03, 2014 | 877,253 | 3.5% |
| MINDSPEED TECHNOLOGIES, INC | December 13, 2013 | 2,068,416 | 4.8% |
| TRANSGENOMIC INC | November 01, 2013 | 13,744,086 | 15.6% |
| OCLARO, INC. | September 20, 2013 | 8,592,517 | 9.3% |
| SUPERCONDUCTOR TECHNOLOGIES INC | December 21, 2012 | 8,776,335 | 17.4% |
View KOPP INVESTMENT ADVISORS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR/A | 2018-08-15 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-14 |
| 13F-HR | 2018-02-14 |
| 13F-HR | 2017-11-14 |
View KOPP INVESTMENT ADVISORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.